Find similar content

Source channel @githubtrending · Post #15433 · Jan 23

#python#deepseek#demo#easy#embedding#flask#gpt#huggingface_transformers#llm#mcp#multimodal#openai#qwen#rag#sentence_transformers#ui#vllm#vlm UltraRAG is a lightweight framework that makes building retrieval-augmented generation (RAG) systems simple and fast. It uses a low-code approach where you write just dozens of lines of YAML configuration instead of complex code to create sophisticated AI workflows with conditional logic and loops. The framework includes a visual development environment where you can drag-and-drop to build pipelines, adjust parameters in real-time, and instantly convert your logic into interactive chat applications. This means you can deploy powerful AI systems that ground answers in your own data—reducing hallucinations and improving accuracy—without needing extensive coding expertise or lengthy development cycles. https://github.com/OpenBMB/UltraRAG

Hashtags

#python #deepseek #demo #easy #embedding #flask #gpt #huggingface_transformers #llm #mcp #multimodal #openai #qwen #rag #sentence_transformers #ui #vllm #vlm

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment